Optimization of the Treatment of Adults With Precursor Lymphoid Neoplasms With Adjustment of the Type and Intensity of the Therapy for Age, Status of Minimal Residual Disease, Genetic and Phenotypic Features
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Alvocidib; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Etoposide; Imatinib; Mercaptopurine; Methotrexate; Mitoxantrone; Pegaspargase; Prednisone; Procarbazine; Vincristine
- Indications Lymphoma
- Focus Pharmacogenomic; Therapeutic Use
- 23 Aug 2012 New trial record
- 17 Aug 2012 Biomarkers information updated